Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
about
Evaluation of quinolones in experimental animal models of infections.Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditisPenetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Diffusion of ofloxacin in the endocarditis vegetation assessed with synchrotron radiation UV fluorescence microspectroscopy.CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.Current perspectives on glycopeptide resistance.Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditisComparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infectionPharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection modelDevelopment of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditisAntibiotic prophylaxis and the medically compromised patient.
P2860
Q30446615-DD755836-50BA-407D-9F68-77ED53C57C4CQ33689451-75A57AAD-98D0-4D19-A2D8-D418630A44BFQ33693084-9C1AF4A3-F62D-4D74-A49D-756820CF19FCQ33745713-BB14054E-AE6D-459B-9EFC-E60DCF1C0EE3Q33758399-B2DADF6C-50F5-4B47-B4CC-A45E6E89240DQ33894927-4ACF53BC-B80B-4F72-A4D8-8E930D249B50Q34537953-C304E17D-E99A-4597-A46B-3A74D6A1ECECQ35123155-91B4B683-F016-426A-8AFF-5FC4F0798C98Q35368590-C7F7BCAF-0F6A-42D5-87D4-651F6922AE75Q35534742-F3B0B33E-E773-44AC-AE37-1EBADD11FE54Q35821605-178B576C-6581-4D04-98E6-7760EE6A84F7Q35822889-AC44C1FF-0E59-4C7D-A2D2-D3428F118DBFQ36754440-3B260DBE-B7E9-4449-845D-332F36A1ACB9Q41754792-C84C61AB-1482-4D1F-A86E-329B276B4C34
P2860
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@ast
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@en
type
label
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@ast
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@en
prefLabel
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@ast
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@en
P2093
P2860
P356
P1476
Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis
@en
P2093
P2860
P304
P356
10.1128/AAC.34.2.257
P407
P577
1990-02-01T00:00:00Z